{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:58:56Z","timestamp":1760101136395,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Basic Research Project of Peking University Shenzhen Hospital","award":["JCYJ2017001","JCYJ2017004","JCYJ2017005","JCYJ2017006","JCYJ2017007","JCYJ2017012"],"award-info":[{"award-number":["JCYJ2017001","JCYJ2017004","JCYJ2017005","JCYJ2017006","JCYJ2017007","JCYJ2017012"]}]},{"name":"Clinical Research Project of Peking University Shenzhen Hospital","award":["LCYJ2017001"],"award-info":[{"award-number":["LCYJ2017001"]}]},{"name":"Science and Technology Development Fund Project of Shenzhen","award":["JCYJ20180507183102747"],"award-info":[{"award-number":["JCYJ20180507183102747"]}]},{"name":"Clinical Research Project of Shenzhen Health Commission","award":["SZLY2018023"],"award-info":[{"award-number":["SZLY2018023"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.prp.2019.03.019","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T10:59:03Z","timestamp":1552993143000},"page":"152391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Associations of high expression of miR-106b-5p detected from FFPE sample with poor prognosis of RCC patients"],"prefix":"10.1016","volume":"215","author":[{"given":"Kaihao","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiqi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunduo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liwen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqing","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2019.03.019_bib0005","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1102\/1470-7330.2013.9035","article-title":"Metastatic renal cell cancer","volume":"13","author":"Rasmussen","year":"2013","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.prp.2019.03.019_bib0010","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2019.03.019_bib0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0033-1363837","article-title":"Epidemiology and staging of renal cell carcinoma","volume":"31","author":"Ridge","year":"2014","journal-title":"Semin. Interv. Radiol."},{"key":"10.1016\/j.prp.2019.03.019_bib0020","doi-asserted-by":"crossref","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.prp.2019.03.019_bib0025","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.urolonc.2015.10.003","article-title":"Surgical considerations for patients with metastatic renal cell carcinoma","volume":"33","author":"Adibi","year":"2015","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.prp.2019.03.019_bib0030","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2147\/OTT.S56370","article-title":"Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma","volume":"7","author":"Nerich","year":"2014","journal-title":"Onco. Ther."},{"key":"10.1016\/j.prp.2019.03.019_bib0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3233\/CBM-160676","article-title":"Functional analysis of serum microRNAs miR-21 and miR-106a in renal cell carcinoma","volume":"18","author":"Tusong","year":"2017","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.prp.2019.03.019_bib0040","first-page":"235","article-title":"microRNAs and ceRNAs: RNA networks in pathogenesis of cancer","volume":"25","author":"Su","year":"2013","journal-title":"Chin. J. Cancer Res."},{"key":"10.1016\/j.prp.2019.03.019_bib0045","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.eururo.2011.01.044","article-title":"MicroRNA in prostate, bladder, and kidney cancer: a systematic review","volume":"59","author":"Catto","year":"2011","journal-title":"Eur. Urol."},{"issue":"475","key":"10.1016\/j.prp.2019.03.019_bib0050","article-title":"MicroRNAs as biomarkers associated with bladder cancer","volume":"30","author":"Homami","year":"2016","journal-title":"Med. J. Islam. Repub. Iran"},{"key":"10.1016\/j.prp.2019.03.019_bib0055","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cell.2005.06.036","article-title":"miRNAs, cancer, and stem cell division","volume":"122","author":"Croce","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.prp.2019.03.019_bib0060","doi-asserted-by":"crossref","first-page":"13491","DOI":"10.18632\/oncotarget.4821","article-title":"miR-449a promotes liver cancer cell apoptosis by downregulation of Calpain 6 and POU2F1","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2019.03.019_bib0065","doi-asserted-by":"crossref","first-page":"23297","DOI":"10.18632\/oncotarget.4195","article-title":"The role of microRNAs expression in laryngeal cancer","volume":"6","author":"Yu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2019.03.019_bib0070","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.3892\/ijo.2016.3746","article-title":"miR-19a correlates with poor prognosis of clear cell renal cell carcinoma patients via promoting cell proliferation and suppressing PTEN\/SMAD4 expression","volume":"49","author":"Ma","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.prp.2019.03.019_bib0075","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.252","article-title":"The putative tumor suppressor microRNA-30a-5p modulates clear cell renal cell carcinoma aggressiveness through repression of ZEB2","volume":"8","author":"Chen","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.prp.2019.03.019_bib0080","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2147\/OTT.S115791","article-title":"Expression of microRNA-30c via lentivirus vector inhibits the proliferation and enhances the sensitivity of highly aggressive ccRCC Caki-1 cells to anticancer agents","volume":"10","author":"Yang","year":"2017","journal-title":"Onco. Ther."},{"key":"10.1016\/j.prp.2019.03.019_bib0085","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/948408","article-title":"Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles","volume":"2014","author":"Muller","year":"2014","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.prp.2019.03.019_bib0090","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.3892\/mmr.2015.4656","article-title":"MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis","volume":"13","author":"Li","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"9","key":"10.1016\/j.prp.2019.03.019_bib0095","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/jamacardio.2018.2371","article-title":"Associations of circulating extracellular RNAs with myocardial remodeling and heart failure","volume":"3","author":"Shah","year":"2018","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.prp.2019.03.019_bib0100","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1038\/s41388-018-0239-7","article-title":"The miR-106b-25 cluster mediates breast tumor initiation through activation of NOTCH1 via direct repression of NEDD4L","volume":"37","author":"Guarnieri","year":"2018","journal-title":"Oncogene"},{"issue":"44","key":"10.1016\/j.prp.2019.03.019_bib0105","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1038\/s41388-018-0367-0","article-title":"Identification of microR-106b as a prognostic biomarker of p53-like bladder cancers by ActMiR","volume":"37","author":"Lee","year":"2018","journal-title":"Oncogene"},{"issue":"226","key":"10.1016\/j.prp.2019.03.019_bib0110","article-title":"Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma","volume":"9","author":"Li","year":"2014","journal-title":"Diagn. Pathol."},{"issue":"6","key":"10.1016\/j.prp.2019.03.019_bib0115","doi-asserted-by":"crossref","first-page":"367","DOI":"10.29252\/.22.6.367","article-title":"Up-Regulation of miR-21, miR-25, miR-93, and miR-106b in Gastric Cancer","volume":"22","author":"LArki","year":"2018","journal-title":"Iran. Biomed. J."},{"key":"10.1016\/j.prp.2019.03.019_bib0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096670","article-title":"MicroRNA profiles discriminate among colon cancer metastasis","volume":"9","author":"Drusco","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2019.03.019_bib0125","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.prp.2019.03.019_bib0130","doi-asserted-by":"crossref","first-page":"14653","DOI":"10.1007\/s13277-016-5310-9","article-title":"MiR-429 is linked to metastasis and poor prognosis in renal cell carcinoma by affecting epithelial-mesenchymal transition","volume":"37","author":"Machackova","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.prp.2019.03.019_bib0135","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.juro.2013.12.046","article-title":"Continued increase in incidence of renal cell carcinoma, especially in young patients and high grade disease: united States 2001 to 2010","volume":"191","author":"King","year":"2014","journal-title":"J. Urol."},{"issue":"63","key":"10.1016\/j.prp.2019.03.019_bib0140","first-page":"11","article-title":"Cancer statistics, 2013","author":"Siegel","year":"2013","journal-title":"CA Cancer J. Clin."},{"issue":"66","key":"10.1016\/j.prp.2019.03.019_bib0145","first-page":"115","article-title":"Cancer statistics in China","volume":"2016","author":"Chen","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.prp.2019.03.019_bib0150","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.mam.2015.06.004","article-title":"Biomarkers for evaluating racial disparities in clinical outcome in patients with renal cell carcinoma","volume":"45","author":"Harris","year":"2015","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.prp.2019.03.019_bib0155","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1159\/000492561","article-title":"Increased cellular levels of MicroRNA-9 and MicroRNA-221 correlate with Cancer stemness and predict poor outcome in human breast Cancer","volume":"48","author":"Cheng","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.prp.2019.03.019_bib0160","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1177\/0004563218755815","article-title":"Diagnostic and prognostic potential of serum miR-132\/212 cluster in patients with hepatocellular carcinoma","volume":"55","author":"Wang","year":"2018","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.prp.2019.03.019_bib0165","doi-asserted-by":"crossref","first-page":"19136","DOI":"10.18632\/oncotarget.24927","article-title":"Assessment of micro RNAs expression in leukemic cells as prognostic markers in chronic lymphocytic leukemia: micro RNAs can predict survival in a course of the disease","volume":"9","author":"Szymczyk","year":"2018","journal-title":"Oncotarget."},{"issue":"700","key":"10.1016\/j.prp.2019.03.019_bib0170","article-title":"Elevated expression of tumor miR-222 in pancreatic cancer is associated with Ki67 and poor prognosis","volume":"30","author":"Lee","year":"2013","journal-title":"Med. Oncol."},{"key":"10.1016\/j.prp.2019.03.019_bib0175","doi-asserted-by":"crossref","first-page":"18773","DOI":"10.18632\/oncotarget.13095","article-title":"Investigation on tissue specific effects of pro-apoptotic micro RNAs revealed miR-147b as a potential biomarker in ovarian cancer prognosis","volume":"8","author":"Kleemann","year":"2017","journal-title":"Oncotarget"},{"issue":"90","key":"10.1016\/j.prp.2019.03.019_bib0180","article-title":"Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy","volume":"29","author":"Slaby","year":"2010","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.prp.2019.03.019_bib0185","article-title":"Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis","volume":"7","author":"Wu","year":"2012","journal-title":"PLoS One"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033818313906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033818313906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:36:46Z","timestamp":1759732606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033818313906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0344033818313906"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2019.03.019","relation":{},"ISSN":["0344-0338"],"issn-type":[{"type":"print","value":"0344-0338"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations of high expression of miR-106b-5p detected from FFPE sample with poor prognosis of RCC patients","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2019.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152391"}}